EGF and neoplasm: Actually, there is no evidence that conventional chemotherapy improves survival rates in these patients, while some results can be observed by using new molecules (cetuximab, epidermal growth factor monoclonal antibody) combined with adjuvant radiotherapy in patients with positive tumour primary margins and extracapsular lymph node spread [125,126,127].